51144-19-5

Usage

Structure

Hydrazone derivative of 3-methyl-2(1H)-quinoxalinone

Classification

Quinoxalinone compound

Potential applications

Pharmaceutical research and drug development

Biological activity

Unique

Need for further research

To fully understand properties and potential uses

Upstream product

• 32601-86-8 2-chloro-3-methylquinoxaline 
• 95-54-5 1,2-diamino-benzene 
• 14003-34-0 3-methyl-2-oxo-1,2-dihydroquinoxaline 
• 14003-34-0 3-methylquinoxalin-2-ol 

Downstream Products

• 198709-45-4 2-(3-Methyl-quinoxalin-2-yl)-5-phenyl-2H-pyrazol-3-ylamine 
• 198709-51-2 2-(3-Methyl-quinoxalin-2-yl)-5-p-tolyl-2H-pyrazol-3-ylamine 
• 198709-49-8 5-(4-Chloro-phenyl)-2-(3-methyl-quinoxalin-2-yl)-2H-pyrazol-3-ylamine 
• 198709-47-6 5-(4-Bromo-phenyl)-2-(3-methyl-quinoxalin-2-yl)-2H-pyrazol-3-ylamine 
• 947265-35-2 (N'-(furan-2-ylmethylidene)hydrazino)-3-methylquinoxaline 
• 420106-35-0 2-[(3-methyl-quinoxalin-2-yl)-hydrazonomethyl]-phenol 
• 463367-97-7 2-(N'-(2-chlorobenzylidene)hydrazino)-3-methylquinoxaline 
• 307506-49-6 4-[(3-methyl-quinoxalin-2-yl)-hydrazonomethyl]-phenol 
• 420106-07-6 3-methyl-2-(4'-methoxybenzylidene)hydrazinoquinoxaline 
• 420107-08-0 2-methoxy-6-[(3-methyl-quinoxalin-2-yl)-hydrazonomethyl]-phenol 
• 463957-43-9 N-(3-Methyl-quinoxalin-2-yl)-N'-[(E)-3-phenyl-prop-2-en-(E)-ylidene]-hydrazine 
• 463368-18-5 2-(N'-(2-nitrobenzylidene)hydrazino)-3-methylquinoxaline 

Relevant academic research and scientific papers

TRIAZOLOPYRAZINE DERIVATIVES AND THEIR USE FOR TREATING NEUROLOGICAL AND PSYCHIATRIC DISORDERS

The present invention is directed to triazolopyrazine compounds of Formula (I). Separate aspects of the invention are directed to pharmaceutical compositions comprising said compounds and uses of the compounds as therapeutic agents treating neurological and psychiatric disorders.

Synthesis and antimicrobial activity of 2-substituted benzyl hydrazino-3-methyl quinoxalines

Reduction of 3-methyl-2-(arylidcne hydrazino)quinoxalines 5a-1 with NaBH4 in controlled experimental conditions to give the 2-substituted benzyl hydrazine-3-methyl quinoxalines 6a-l have been described. The structure of compounds 6a-l have been confirmed from elemental analysis, IR, 1H NMR and mass spectral data. All the compounds have been screened for their antimicrobial activity against several microbes.